Aytu Biopharma (AYTU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.04, +1.49% vs the prior close of $2.01.
- Volume 29.95K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AYTU rises 1.5% to $2.04. Closed at $2.04, +1.49% vs the prior close of $2.01. Day range $1.96–$2.14, opened at $2.00.
AYTU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AYTU rises 1.5% to $2.04
- Closed at $2.04, +1.49% vs the prior close of $2.01. Day range $1.96–$2.14, opened at $2.00.
- Volume was 29.95K shares, 0.8x its 50-day average of 36.90K.
- Price is -6.6% vs its 50-day average ($2.18) and -13.4% vs its 200-day average ($2.36).
- 52-week range $1.80–$3.07; today's close sits at 19% of that range, 33.6% below the 52-week high.
Oct 15, 2026 — AYTU jumps 3.1% to $2.01
- Closed at $2.01, +3.08% vs the prior close of $1.95. Day range $1.95–$2.02, opened at $1.96.
- Volume was 29.30K shares, 0.8x its 50-day average of 37.31K.
- Price is -8.2% vs its 50-day average ($2.19) and -14.8% vs its 200-day average ($2.36).
- 52-week range $1.80–$3.07; today's close sits at 17% of that range, 34.5% below the 52-week high.
Oct 14, 2026 — AYTU dips 2.0% to $1.95, a 6-month low
- Closed at $1.95, -2.01% vs the prior close of $1.99. Day range $1.94–$2.05, opened at $1.95.
- Volume was 30.40K shares, 0.8x its 50-day average of 37.15K.
- Price is -11.2% vs its 50-day average ($2.20) and -17.4% vs its 200-day average ($2.36).
- 52-week range $1.80–$3.07; today's close sits at 12% of that range, 36.5% below the 52-week high.
Oct 13, 2026 — AYTU rises 1.0% to $1.99
- Closed at $1.99, +1.02% vs the prior close of $1.97. Day range $1.95–$2.03, opened at $1.96.
- Volume was 24.50K shares, 0.7x its 50-day average of 37.13K.
- Price is -9.6% vs its 50-day average ($2.20) and -15.8% vs its 200-day average ($2.36).
- 52-week range $1.80–$3.07; today's close sits at 15% of that range, 35.2% below the 52-week high.
Oct 12, 2026 — AYTU dips 3.0% to $1.97, 4 down days in a row
- Closed at $1.97, -2.96% vs the prior close of $2.03. Day range $1.96–$2.04, opened at $1.99.
- Volume was 23.20K shares, 0.6x its 50-day average of 38.13K.
- Price is -10.7% vs its 50-day average ($2.21) and -16.7% vs its 200-day average ($2.37).
- 52-week range $1.80–$3.07; today's close sits at 13% of that range, 35.8% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — AYTU dips 1.0% to $2.03, 3 down days in a row
- Closed at $2.03, -0.98% vs the prior close of $2.05. Day range $2.02–$2.07, opened at $2.04.
- Volume was 10.50K shares, 0.3x its 50-day average of 38.33K — lighter than usual.
- Price is -8.2% vs its 50-day average ($2.21) and -14.3% vs its 200-day average ($2.37).
- 52-week range $1.80–$3.07; today's close sits at 18% of that range, 33.9% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — AYTU ends flat (+0.0%) to $2.05
- Closed at $2.05, +0.00% vs the prior close of $2.05. Day range $2.05–$2.09, opened at $2.05.
- Volume was 5.60K shares, 0.1x its 50-day average of 39.07K — lighter than usual.
- Price is -7.4% vs its 50-day average ($2.21) and -13.6% vs its 200-day average ($2.37).
- 52-week range $1.80–$3.07; today's close sits at 20% of that range, 33.2% below the 52-week high.
Oct 7, 2026 — AYTU ends flat (+0.0%) to $2.05
- Closed at $2.05, +0.00% vs the prior close of $2.05. Day range $2.03–$2.10, opened at $2.04.
- Volume was 5.70K shares, 0.1x its 50-day average of 39.38K — lighter than usual.
- Price is -7.4% vs its 50-day average ($2.21) and -13.7% vs its 200-day average ($2.37).
- 52-week range $1.80–$3.07; today's close sits at 20% of that range, 33.2% below the 52-week high.
Oct 6, 2026 — AYTU rises 0.5% to $2.05
- Closed at $2.05, +0.49% vs the prior close of $2.04. Day range $2.02–$2.09, opened at $2.05.
- Volume was 21.60K shares, 0.5x its 50-day average of 39.71K — lighter than usual.
- Price is -7.5% vs its 50-day average ($2.22) and -13.7% vs its 200-day average ($2.38).
- 52-week range $1.80–$3.07; today's close sits at 20% of that range, 33.2% below the 52-week high.
Oct 5, 2026 — AYTU dips 1.4% to $2.04, 4 down days in a row
- Closed at $2.04, -1.45% vs the prior close of $2.07. Day range $2.04–$2.15, opened at $2.05.
- Volume was 63.90K shares, 1.7x its 50-day average of 38.64K.
- Price is -7.9% vs its 50-day average ($2.22) and -14.2% vs its 200-day average ($2.38).
- 52-week range $1.80–$3.07; today's close sits at 19% of that range, 33.6% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — AYTU dips 1.0% to $2.07, 3 down days in a row
- Closed at $2.07, -0.96% vs the prior close of $2.09. Day range $2.06–$2.15, opened at $2.08.
- Volume was 15.80K shares, 0.4x its 50-day average of 38.72K — lighter than usual.
- Price is -6.7% vs its 50-day average ($2.22) and -13.1% vs its 200-day average ($2.38).
- 52-week range $1.80–$3.07; today's close sits at 21% of that range, 32.6% below the 52-week high.
- That makes 3 straight losses.
AYTU latest news & SEC filings
Every SEC filing by or about AYTU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 22, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $57.57M (prior year $66.38M) (-13.3% vs Jun 30, 2025)
- Net income: -$14.25M (prior year -$13.56M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.16 (prior year -$2.16) (loss narrowed vs Jun 30, 2025)
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Things to know before you trade AYTU
- Last results release: Sep 22, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Apr 2, 2026, Feb 3, 2026. Based on that rhythm, the next report is likely around Dec 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.79% (largest 4.8%).
- Liquidity: about 51.06K shares (≈$104.16K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.04 vs a range of $1.80–$3.07 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 4 sales; latest: Carl Dockery sold 209 shares on Dec 30, 2020.
- Latest filings: 10-K Sep 22, 2026; 8-K Sep 22, 2026; 8-K Jun 25, 2026.
- Share count: 10.87M shares outstanding (Sep 15, 2026), +9.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AYTU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.00 | 2.14 | 1.96 | 2.04 | 29.95K |
| Oct 15, 2026 | 1.96 | 2.02 | 1.95 | 2.01 | 29.30K |
| Oct 14, 2026 | 1.95 | 2.05 | 1.94 | 1.95 | 30.40K |
| Oct 13, 2026 | 1.96 | 2.03 | 1.95 | 1.99 | 24.50K |
| Oct 12, 2026 | 1.99 | 2.04 | 1.96 | 1.97 | 23.20K |
| Oct 9, 2026 | 2.04 | 2.07 | 2.02 | 2.03 | 10.50K |
| Oct 8, 2026 | 2.05 | 2.09 | 2.05 | 2.05 | 5.60K |
| Oct 7, 2026 | 2.04 | 2.10 | 2.03 | 2.05 | 5.70K |
| Oct 6, 2026 | 2.05 | 2.09 | 2.02 | 2.05 | 21.60K |
| Oct 5, 2026 | 2.05 | 2.15 | 2.04 | 2.04 | 63.90K |
| Oct 2, 2026 | 2.08 | 2.15 | 2.06 | 2.07 | 15.80K |
| Oct 1, 2026 | 2.15 | 2.15 | 2.04 | 2.09 | 29.90K |
| Sep 30, 2026 | 2.18 | 2.20 | 2.13 | 2.14 | 67.70K |
| Sep 29, 2026 | 2.19 | 2.20 | 2.15 | 2.20 | 37.10K |
| Sep 28, 2026 | 2.23 | 2.24 | 2.17 | 2.17 | 16.40K |
| Sep 25, 2026 | 2.28 | 2.29 | 2.21 | 2.28 | 28.20K |
| Sep 24, 2026 | 2.23 | 2.34 | 2.21 | 2.31 | 70.00K |
| Sep 23, 2026 | 2.34 | 2.35 | 2.12 | 2.28 | 187.90K |
| Sep 22, 2026 | 2.18 | 2.33 | 2.14 | 2.23 | 274.10K |
| Sep 21, 2026 | 2.20 | 2.20 | 2.10 | 2.13 | 49.40K |
About Aytu Biopharma
Aytu Biopharma (AYTU) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DENVER, CO. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1385818.
AYTU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carl Dockery | Director | Jul 30, 2026 |
| Joshua R. Disbrow | Chief Executive Officer | Jul 30, 2026 |
| John Jr. Donofrio | Director | Jul 30, 2026 |
| Abhinav Jain | Director | Jul 30, 2026 |
| Vivian H Liu | Director | Jul 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jarrett Disbrow | Chief Business Officer | Jul 30, 2026 |
| Joshua R. Disbrow | Chief Executive Officer | Jul 30, 2026 |
| Greg Pyszczymuka | Chief Commercial Officer | Jul 30, 2026 |
| Ryan J Selhorn | Chief Financial Officer | Jul 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 30, 2020 | Carl Dockery | Sale | 209 | $6.01 |
| Dec 30, 2020 | Carl Dockery | Sale | 209 | $6.01 |
| Dec 30, 2020 | Carl Dockery | Sale | 209 | $6.01 |
| Dec 30, 2020 | Carl Dockery | Sale | 209 | $6.01 |
| Nov 18, 2020 | Carl Dockery | Buy | 10,000 | $0.92 |
| Nov 18, 2020 | Carl Dockery | Buy | 10,000 | $0.92 |
| Nov 18, 2020 | Carl Dockery | Buy | 10,000 | $0.92 |
| Nov 18, 2020 | Carl Dockery | Buy | 10,000 | $0.92 |
AYTU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $57.57M | $-14.25M | — | $3.28M |
| Jun 30, 2025 | $66.38M | $-13.56M | — | $-1.94M |
| Jun 30, 2024 | $65.18M | $-15.84M | — | $-1.39M |
| Jun 30, 2023 | $107.40M | $-17.05M | -5.11 | $-5.13M |
| Jun 30, 2022 | $96.67M | $-108.78M | -74.01 | $-28.82M |
Latest balance sheet: total assets $105.01M, total liabilities $100.72M, cash $26.31M (as of Jun 30, 2026).
AYTU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 22, 2026 | 8-K Item 2.02 (results) | $2.23 |
| May 13, 2026 | 8-K Item 2.02 (results) | $2.25 |
| Apr 2, 2026 | 8-K Item 2.02 (results) | $2.68 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $2.62 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $2.06 |
| Sep 23, 2025 | 8-K Item 2.02 (results) | $2.51 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.35 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $1.39 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $1.75 |
| Sep 26, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Feb 14, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AYTU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.